Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ILMN – Illumina, Inc.

Illumina, Inc.
ILMN
$95.50
Name : Illumina, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $15,117,649,920.00
EPSttm : -6.08
finviz dynamic chart for ILMN
Illumina, Inc.
$95.50
0.09%
$0.09

Float Short %

4.1

Margin Of Safety %

-30

Put/Call OI Ratio

0.17

EPS Next Q Diff

0.11

EPS Last/This Y

11.92

EPS This/Next Y

0.44

Price

95.42

Target Price

103.75

Analyst Recom

2.32

Performance Q

19.26

Relative Volume

0.8

Beta

1.36

Ticker: ILMN




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02ILMN81.110.230.7877397
2025-06-03ILMN81.820.230.3378478
2025-06-04ILMN83.180.230.5079418
2025-06-05ILMN82.30.230.6879695
2025-06-06ILMN82.630.230.0779929
2025-06-09ILMN84.960.210.0985025
2025-06-10ILMN880.190.1493933
2025-06-11ILMN87.550.180.2999499
2025-06-12ILMN88.120.191.88100511
2025-06-13ILMN86.730.191.04100719
2025-06-16ILMN90.280.190.5398749
2025-06-17ILMN89.510.192.18100332
2025-06-18ILMN90.280.190.15101064
2025-06-20ILMN90.490.190.59101384
2025-06-23ILMN90.670.180.8785021
2025-06-24ILMN91.540.190.3085599
2025-06-25ILMN93.210.190.1585926
2025-06-26ILMN94.210.190.0786607
2025-06-27ILMN94.840.170.4497577
2025-06-30ILMN95.480.171.0896039
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02ILMN81.11179.91687.44.23
2025-06-03ILMN81.83179.91706.44.23
2025-06-04ILMN83.17179.91712.44.23
2025-06-05ILMN82.25179.91689.84.23
2025-06-06ILMN82.64179.91702.94.23
2025-06-09ILMN84.98179.91722.24.23
2025-06-10ILMN88.00180.41728.54.23
2025-06-11ILMN87.58180.41695.14.23
2025-06-12ILMN88.13180.41704.54.23
2025-06-13ILMN86.95180.41687.64.23
2025-06-16ILMN90.30180.41731.34.23
2025-06-17ILMN89.53180.41692.24.23
2025-06-18ILMN90.26180.41706.34.23
2025-06-20ILMN90.49180.51701.04.23
2025-06-23ILMN90.62180.51700.14.23
2025-06-24ILMN91.52196.41707.34.42
2025-06-25ILMN93.26196.41714.84.42
2025-06-26ILMN94.22180.51707.54.23
2025-06-27ILMN94.84180.51704.94.23
2025-06-30ILMN95.42180.51704.54.23
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02ILMN0.401.433.97
2025-06-03ILMN0.401.433.97
2025-06-04ILMN0.401.433.97
2025-06-05ILMN0.401.433.97
2025-06-06ILMN0.401.433.97
2025-06-09ILMN0.401.413.97
2025-06-10ILMN0.401.413.97
2025-06-11ILMN0.401.413.57
2025-06-12ILMN0.401.413.57
2025-06-13ILMN0.401.413.57
2025-06-16ILMN0.401.803.57
2025-06-18ILMN0.401.803.57
2025-06-20ILMN0.401.803.57
2025-06-23ILMN0.401.463.57
2025-06-24ILMN0.401.463.57
2025-06-25ILMN0.401.463.57
2025-06-26ILMN0.401.464.10
2025-06-27ILMN0.401.464.10
2025-06-30ILMN0.401.244.10
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

0.97

Avg. EPS Est. Current Quarter

1.01

Avg. EPS Est. Next Quarter

1.08

Insider Transactions

0.4

Institutional Transactions

1.24

Beta

1.36

Average Sales Estimate Current Quarter

1048

Average Sales Estimate Next Quarter

1054

Fair Value

67.05

Quality Score

42

Growth Score

36

Sentiment Score

61

Actual DrawDown %

82.3

Max Drawdown 5-Year %

-86.2

Target Price

103.75

P/E

Forward P/E

20.53

PEG

P/S

3.48

P/B

6.41

P/Free Cash Flow

17.24

EPS

-6.1

Average EPS Est. Cur. Y​

4.23

EPS Next Y. (Est.)

4.67

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-22.25

Relative Volume

0.8

Return on Equity vs Sector %

-64.6

Return on Equity vs Industry %

-51.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

1704.5
Illumina, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 8970
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
stock quote shares ILMN – Illumina, Inc. Stock Price stock today
news today ILMN – Illumina, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ILMN – Illumina, Inc. yahoo finance google finance
stock history ILMN – Illumina, Inc. invest stock market
stock prices ILMN premarket after hours
ticker ILMN fair value insiders trading